Lin Patrick P, Guzel Volkan B, Pisters Peter W T, Zagars Gunar K, Weber Kristin L, Feig Barry W, Pollock Raphael E, Yasko Alan W
Section of Orthopaedic Oncology, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
Cancer. 2002 Aug 15;95(4):852-61. doi: 10.1002/cncr.10750.
Soft tissue sarcomas of the hand and foot present unique management challenges. The purpose of the current study study was to determine oncologic outcome, particularly with respect to factors affecting local recurrence, distant recurrence, and disease-specific survival.
A retrospective study was performed on 115 patients with soft tissue sarcomas of the hand or foot who were evaluated, treated, and followed at the authors' institution between 1980 and 1998. The medical records and radiographs were reviewed. Kaplan-Meier analysis was used to assess patient survival.
Most patients (95%) were referred after previous surgery. The majority of tumors (75%) were T1 lesions (less than 5 cm), and most tumors (81%) were high grade. Patients who were treated by definitive, wide re-excision (n = 43) had a 10 year local recurrence-free survival of 88%, which was significantly better than the corresponding rate of 58% for patients who did not have re-excision (n = 40, P = 0.05). Radiation improved local control in patients who did not undergo re-excision (n = 17, P = 0.02). However, radiation did not improve local control in patients who had definitive re-excision with negative margins (n = 13, P = 0.51). The disease-specific survival at 5 and 10 years was 76% and 65%, respectively, for patients who presented with localized disease. Disease-specific patient survival was significantly worse for patients who had regional or distant metastasis. Radical amputation as initial surgical treatment did not decrease the likelihood of regional metastasis and did not improve disease-specific patient survival. The presence of distant metastasis at presentation was an independent predictor of local recurrence.
Limb sparing treatment is possible in many patients with soft tissue sarcomas of the hand and foot. Re-excision to achieve microscopically negative surgical margins is an effective method of achieving a high rate of local control in appropriately selected patients who present after unplanned excision of the primary tumor. There does not appear to be a survival benefit to immediate radical amputation, which should be reserved for cases where surgical excision or re-excision with adequate margins cannot be performed without sacrifice of functionally significant neurovascular or osseous structures.
手足部软组织肉瘤的治疗面临独特挑战。本研究的目的是确定肿瘤学结局,尤其是关于影响局部复发、远处复发和疾病特异性生存的因素。
对1980年至1998年间在作者所在机构接受评估、治疗和随访的115例手足部软组织肉瘤患者进行回顾性研究。查阅病历和X光片。采用Kaplan-Meier分析评估患者生存率。
大多数患者(95%)在先前手术后转诊。大多数肿瘤(75%)为T1期病变(小于5厘米),且大多数肿瘤(81%)为高级别。接受确定性广泛再次切除的患者(n = 43)10年局部无复发生存率为88%,显著高于未进行再次切除的患者(n = 40)的相应比率58%(P = 0.05)。放疗改善了未进行再次切除患者的局部控制(n = 17,P = 0.02)。然而,放疗并未改善切缘阴性的确定性再次切除患者的局部控制(n = 13,P = 0.51)。局限性疾病患者5年和10年的疾病特异性生存率分别为76%和65%。有区域或远处转移的患者疾病特异性生存率明显更差。作为初始手术治疗的根治性截肢并未降低区域转移的可能性,也未改善患者的疾病特异性生存率。就诊时存在远处转移是局部复发的独立预测因素。
许多手足部软组织肉瘤患者可以进行保肢治疗。再次切除以达到显微镜下切缘阴性是在原发性肿瘤意外切除后就诊的适当选择患者中实现高局部控制率的有效方法。立即进行根治性截肢似乎没有生存益处,应仅用于不牺牲功能重要的神经血管或骨性结构就无法进行手术切除或有足够切缘的再次切除的病例。